首页> 外文OA文献 >Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management
【2h】

Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management

机译:用地塞米松玻璃体植入物治疗Birdshot胆体胰蛋白病和生物反应改性剂:成功的管理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.
机译:Birdshot ChorioreTinopathy是一种器官特异性,可能致盲的后眼部末端炎症的慢性。它主要是在具有HLA-A29单倍型的人中。诊断仍然是临床,并且基于他的标志,这是整个眼底的倍数白点的存在,类似于霰弹枪模式。涉及其发病机制的免疫机制仍然尚不清楚,长期结果被保护。然而,使用免疫抑制剂和更新的疗法证明了对炎症的控制,并且是主要在难治性情况下的希望。我们报告了用类固醇和免疫抑制剂成功治疗的Bircshot胆体胰蛋白病的病例。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号